View Financial HealthNovanta 配当と自社株買い配当金 基準チェック /16Novanta配当を支払う会社であり、現在の利回りは2.37%です。主要情報2.4%配当利回り-10.0%バイバック利回り総株主利回り-10.0%将来の配当利回りn/a配当成長n/a次回配当支払日n/a配当落ち日n/a一株当たり配当金n/a配当性向n/a最近の配当と自社株買いの更新更新なしすべての更新を表示Recent updatesお知らせ • Jun 11Novanta Inc. (NasdaqGS:NOVT) entered into a definitive agreement to acquire Riverpoint Medical, LLC from Arlington Capital Partners V, L.P., a fund managed by Arlington Management Employees, LLC for $1.5 billion.Novanta Inc. (NasdaqGS:NOVT) entered into a definitive agreement to acquire Riverpoint Medical, LLC from Arlington Capital Partners V, L.P., a fund managed by Arlington Management Employees, LLC for $1.5 billion on June 8, 2026. A cash consideration of $1.2 billion will be paid by Novanta Inc. Novanta Inc. will pay a milestone payment of $250 million in the first quarter of 2027. Upon completion of the transaction, Riverpoint Medical will be reported under Novanta’s Medical Solutions operating segment. The transaction will be financed through a combination of cash on hand and Novanta’s existing credit facility, and the recently completed $300 million equity raise. The transaction is subject to customary regulatory approvals and the expiration or termination of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976. The transaction is expected to close in the third quarter of 2026. The transaction is expected to be immediately accretive in 2026 to Novanta’s Adjusted Diluted Earnings Per Share, and in 2027 accretive to revenue growth rate, Adjusted Gross and EBITDA Margins, Adjusted Diluted Earnings Per Share, and Operating Cash Flows. Robert W. Baird & Co. Incorporated acted as financial advisor for Novanta Inc. Jefferies LLC acted as financial advisor for Riverpoint Medical, LLC. J.P. Morgan Securities LLC acted as financial advisor for Novanta Inc. King & Spalding LLP acted as legal advisor for Novanta Inc. Matthew J. Byron, Melissa Rones, Emily Karlberg, Renata Ferrari, Pamela Glazier, Samer Musallam, Lisa Kaltenbrunner, Emerson Siegle, Deidre Johnson, Ryan Murphey, Rebecca Liu, Heather Sprague, Alison McLaughlin, and Kurt Fowler of Ropes & Gray LLP acted as legal advisor for Novanta Inc. Joshua Klatzkin, Matthew M. Mauney, and Michael Amalfe of Goodwin Procter LLP acted as legal advisor for Riverpoint Medical, LLC.お知らせ • Jun 10Novanta Inc. announced that it expects to receive $299.99998 million in fundingNovanta Inc. entered into a Securities Purchase Agreement and announced a private placement of 2,142,857 Common Shares of the company at an issue price of $140 for gross proceeds up to $300.0 million on June 8, 2026. The transaction involves participation from institutional and other accredited investors. The private placement is expected to close on or about June 11, 2026, subject to satisfaction of customary closing conditions.お知らせ • May 12Novanta Inc. Provides Earnings Guidance for the Second Quarter and Full Year of 2026Novanta Inc. provided earnings guidance for the second quarter and full year of 2026. For the quarter, the company expects GAAP revenue to be in the range of $259 million to $264 million. For the year, the company expects GAAP revenue to be in the range of $1,040 million to $1,055 million.お知らせ • Apr 14Novanta Inc. to Report Q1, 2026 Results on May 11, 2026Novanta Inc. announced that they will report Q1, 2026 results at 4:00 PM, US Eastern Standard Time on May 11, 2026お知らせ • Feb 24Novanta Inc. Provides Revenue Guidance for the First Quarter and for the Full Year 2026Novanta Inc. provided revenue guidance for the first quarter and For the full year 2026. For the first quarter of 2026, the Company expects GAAP revenue to be in the range of $250 million to $255 million. For the full year, the Company expects GAAP revenue to be in the range of $1,030 million to $1,050 million.お知らせ • Feb 10Novanta Inc., Annual General Meeting, May 28, 2026Novanta Inc., Annual General Meeting, May 28, 2026.お知らせ • Jan 22Novanta Inc. to Report Q4, 2025 Results on Feb 24, 2026Novanta Inc. announced that they will report Q4, 2025 results Pre-Market on Feb 24, 2026お知らせ • Nov 07Novanta Inc. has completed a Composite Units Offering in the amount of $550 million.Novanta Inc. has completed a Composite Units Offering in the amount of $550 million. Security Name: Units Security Type: Debt/Equity Composite Units Securities Offered: 11,000,000 Price\Range: $50 Discount Per Security: $1.375決済の安定と成長配当データの取得安定した配当: NOVT.Uの 1 株当たり配当が過去に安定していたかどうかを判断するにはデータが不十分です。増加する配当: NOVT.Uの配当金が増加しているかどうかを判断するにはデータが不十分です。配当利回り対市場Novanta 配当利回り対市場NOVT.U 配当利回りは市場と比べてどうか？セグメント配当利回り会社 (NOVT.U)2.4%市場下位25% (US)1.4%市場トップ25% (US)4.2%業界平均 (Electronic)0.7%アナリスト予想 (NOVT.U) (最長3年)n/a注目すべき配当: NOVT.Uの配当金 ( 2.37% ) はUS市場の配当金支払者の下位 25% ( 1.38% ) よりも高くなっています。高配当: NOVT.Uの配当金 ( 2.37% ) はUS市場の配当金支払者の上位 25% ( 4.21% ) と比較すると低いです。株主への利益配当収益カバレッジ: NOVT.Uの 配当性向 を計算して配当金の支払いが利益で賄われているかどうかを判断するにはデータが不十分です。株主配当金キャッシュフローカバレッジ: NOVT.Uが配当金を報告していないため、配当金の持続可能性を計算できません。高配当企業の発掘7D1Y7D1Y7D1YUS 市場の強力な配当支払い企業。View Management企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/06/23 12:22終値2026/06/23 00:00収益2026/04/03年間収益2025/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレークこのレポートを生成するために使用した分析モデルの詳細は、当社の Github ページ でご覧いただけます。また、レポートの使い方に関する ガイド や YouTube の チュートリアル もご用意しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Novanta Inc. 3 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。8 アナリスト機関Robert MasonBairdQuinn FredricksonBairdAndrew BuscagliaBerenberg5 その他のアナリストを表示
お知らせ • Jun 11Novanta Inc. (NasdaqGS:NOVT) entered into a definitive agreement to acquire Riverpoint Medical, LLC from Arlington Capital Partners V, L.P., a fund managed by Arlington Management Employees, LLC for $1.5 billion.Novanta Inc. (NasdaqGS:NOVT) entered into a definitive agreement to acquire Riverpoint Medical, LLC from Arlington Capital Partners V, L.P., a fund managed by Arlington Management Employees, LLC for $1.5 billion on June 8, 2026. A cash consideration of $1.2 billion will be paid by Novanta Inc. Novanta Inc. will pay a milestone payment of $250 million in the first quarter of 2027. Upon completion of the transaction, Riverpoint Medical will be reported under Novanta’s Medical Solutions operating segment. The transaction will be financed through a combination of cash on hand and Novanta’s existing credit facility, and the recently completed $300 million equity raise. The transaction is subject to customary regulatory approvals and the expiration or termination of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976. The transaction is expected to close in the third quarter of 2026. The transaction is expected to be immediately accretive in 2026 to Novanta’s Adjusted Diluted Earnings Per Share, and in 2027 accretive to revenue growth rate, Adjusted Gross and EBITDA Margins, Adjusted Diluted Earnings Per Share, and Operating Cash Flows. Robert W. Baird & Co. Incorporated acted as financial advisor for Novanta Inc. Jefferies LLC acted as financial advisor for Riverpoint Medical, LLC. J.P. Morgan Securities LLC acted as financial advisor for Novanta Inc. King & Spalding LLP acted as legal advisor for Novanta Inc. Matthew J. Byron, Melissa Rones, Emily Karlberg, Renata Ferrari, Pamela Glazier, Samer Musallam, Lisa Kaltenbrunner, Emerson Siegle, Deidre Johnson, Ryan Murphey, Rebecca Liu, Heather Sprague, Alison McLaughlin, and Kurt Fowler of Ropes & Gray LLP acted as legal advisor for Novanta Inc. Joshua Klatzkin, Matthew M. Mauney, and Michael Amalfe of Goodwin Procter LLP acted as legal advisor for Riverpoint Medical, LLC.
お知らせ • Jun 10Novanta Inc. announced that it expects to receive $299.99998 million in fundingNovanta Inc. entered into a Securities Purchase Agreement and announced a private placement of 2,142,857 Common Shares of the company at an issue price of $140 for gross proceeds up to $300.0 million on June 8, 2026. The transaction involves participation from institutional and other accredited investors. The private placement is expected to close on or about June 11, 2026, subject to satisfaction of customary closing conditions.
お知らせ • May 12Novanta Inc. Provides Earnings Guidance for the Second Quarter and Full Year of 2026Novanta Inc. provided earnings guidance for the second quarter and full year of 2026. For the quarter, the company expects GAAP revenue to be in the range of $259 million to $264 million. For the year, the company expects GAAP revenue to be in the range of $1,040 million to $1,055 million.
お知らせ • Apr 14Novanta Inc. to Report Q1, 2026 Results on May 11, 2026Novanta Inc. announced that they will report Q1, 2026 results at 4:00 PM, US Eastern Standard Time on May 11, 2026
お知らせ • Feb 24Novanta Inc. Provides Revenue Guidance for the First Quarter and for the Full Year 2026Novanta Inc. provided revenue guidance for the first quarter and For the full year 2026. For the first quarter of 2026, the Company expects GAAP revenue to be in the range of $250 million to $255 million. For the full year, the Company expects GAAP revenue to be in the range of $1,030 million to $1,050 million.
お知らせ • Feb 10Novanta Inc., Annual General Meeting, May 28, 2026Novanta Inc., Annual General Meeting, May 28, 2026.
お知らせ • Jan 22Novanta Inc. to Report Q4, 2025 Results on Feb 24, 2026Novanta Inc. announced that they will report Q4, 2025 results Pre-Market on Feb 24, 2026
お知らせ • Nov 07Novanta Inc. has completed a Composite Units Offering in the amount of $550 million.Novanta Inc. has completed a Composite Units Offering in the amount of $550 million. Security Name: Units Security Type: Debt/Equity Composite Units Securities Offered: 11,000,000 Price\Range: $50 Discount Per Security: $1.375